Medicament for the treatment of choroidal neovascularisation
CA 2474405 A1 · Owner: Brunner, Richard · Inventors: Brunner, Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention refers to the use of 7 S immunoglobulin or an active fraction thereof for the manufacture of a medicament for the treatment of choroidal neovascularaisation and a pharmaceutical composition essentially consisting of an active fraction of 7 S immunoglobulin as pharmaceutically active compound and a method for the treatment of chorodial neovascularisation which comprises administering to the patient a preparation of 7 S immunoglobulin
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.